BRITISH ASSOCIATION FOR CANCER RESEARCH
Latest income
£185k
Latest spending
£189k
Registered
1984
Accounts read
FY2025
Financial health, per its FY2025 accounts
The accounts state that the charity recorded an operating deficit for the year of £3,690. Per the trustees' report, the principal funding sources are capital investment and membership subscriptions, with unrestricted funds totaling £1,490,504 at the end of the period.
What the accounts disclose
Related-party transaction: The Charity is controlled by it's Trustees. There have not been any material transactions with any related party during the year.
“There have not been any material transactions with any related party during the year.” — page 12
Per its FY2025 accounts as filed with the Charity Commission.
Funders the charity credits
- AstraZeneca
Trustees
- Dr George Poulogiannis
- Dr Giorgia Cioccoloni
- Dr Greg Nicholas Brooke
- Dr Jack William Leslie
- Dr Louise Victoria Fets
- Dr Mark Alfred Wade
- Dr Timothy Robert Fenton
- Dr William John Brackenbury
- Prof Antia Grigoriadis
- Prof Charlotte Lynne Bevan
- Professor Joanne Edwards
- Professor Kevin Ryan
Income and spending
| Financial year end | Income | Spending |
|---|---|---|
| 31/03/2025 | £185k | £189k |
| 31/03/2024 | £153k | £216k |
| 31/03/2023 | £167k | £199k |
| 31/03/2022 | £371k | £69k |
| 31/03/2021 | £104k | £66k |
Common questions
Is BRITISH ASSOCIATION FOR CANCER RESEARCH financially healthy?
The accounts state that the charity recorded an operating deficit for the year of £3,690. Per the trustees' report, the principal funding sources are capital investment and membership subscriptions, with unrestricted funds totaling £1,490,504 at the end of the period. Its FY2025 accounts were independently examined.